Skip to search formSkip to main contentSkip to account menu

Ultralente Insulin

Known as: Insulin ultralente, Insulin, Ultralente [Chemical/Ingredient], Insulin, Ultralente 
A long-acting form of crystalline insulin often used in combination with a short-acting insulin in the treatment of diabetes mellitus. Administered… 
National Institutes of Health

Related topics

Related topics

9 relations

Broader (2)

Hypoglycemic AgentsInsulin
In BloodInsulin ultralente:Mass:Pt:Dose:QnProcess of secretionaspects of radiation effects

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2006
2006
Fluctuation of serum basal insulin levels following single and multiple dosing of insulin glargine.
BACKGROUND The large fluctuations in blood concentrations and activity observed with insulin therapies such as NPH insulin or… 
Review
2002
Review
2002
Novel insulins: expanding options in diabetes management.
Review
2001
Review
2001
Update on Major Trials for the Prevention of Type I Diabetes Mellitus: The American Diabetes Prevention Trial (DPT-1) and the European Nicotinamide Diabetes Intervention Trial (ENDIT)
The general population risk of developing type 1 diabetes mellitus (DM), 1/300, is magnified 15-20 fold in first-degree relatives… 
2000
2000
Factors associated with nocturnal hypoglycaemia among patients with type 2 diabetes new to insulin therapy: experience with insulin lispro
Aim: To identify factors associated with nocturnal hypoglycaemia in patients with type 2 diabetes who were new (< 2 months… 
Highly Cited
1987
Highly Cited
1987
Long-Term Use of Intranasal Insulin in Insulin-Dependent Diabetic Patients
This study, in 3 phases, compared the long-term acceptability and efficacy of insulin administered by nasal spray with an… 
1985
1985
The Subcutaneous Absorption of Human and Bovine Ultralente Insulin Formulations
The subcutaneous absorption of 125l‐labelled semisynthetic human ultralente insulin was compared with that of 125l‐labelled beef… 
1985
1985
Abnormal Insulin Secretion in a Streptozocin Model of Diabetes: Effects of Insulin Treatment
We have proposed that chronic hyperglycemia causes the abnormal glucose influence on arginine-stimulated insulin secretion in the… 
Highly Cited
1985
Highly Cited
1985
U.K. Prospective Diabetes Study: II. Reduction in HbA1c with Basal Insulin Supplement, Sulfonylurea, or Biguanide Therapy in Maturity-onset Diabetes
Newly presenting maturity-onset diabetic subjects were put on diet and if, after 3–4 mo, their fasting plasma glucose continued… 
1984
1984
Human ultralente insulin.
The greater solubility of human insulin and its possible faster action have led to doubts about whether a sufficiently long… 
Review
1972
Review
1972
New Forms of Insulin
This paper reviews some recent developments in insulin purification and formulation. Neutral Regular insulin (unbuffered Regular… 
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)